# Registration Trial of the Drug-coated Balloon for the Symptomatic Cerebral Atherosclerotic Stenosis

> **NCT06683118** · NA · ENROLLING_BY_INVITATION · sponsor: **MicroPort NeuroTech Co., Ltd.** · enrollment: 212 (estimated)

## Conditions studied

- Cerebral Atherosclerotic Stenosis

## Interventions

- **DEVICE:** Rapamycin neurovascular Balloon Catheter
- **DEVICE:** Conventional Balloon

## Key facts

- **NCT ID:** NCT06683118
- **Lead sponsor:** MicroPort NeuroTech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-05-27
- **Primary completion:** 2025-07-27
- **Final completion:** 2026-07-27
- **Target enrollment:** 212 (ESTIMATED)
- **Last updated:** 2024-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06683118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06683118, "Registration Trial of the Drug-coated Balloon for the Symptomatic Cerebral Atherosclerotic Stenosis". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06683118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*